Canada House Cannabis Group Inc
CNSX:CHV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (1.5), the stock would be worth CA$0.55 (0% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.5 | CA$0.55 |
0%
|
| 3-Year Average | 1.5 | CA$0.55 |
0%
|
| 5-Year Average | 1.5 | CA$0.55 |
0%
|
| Industry Average | 1 | CA$0.37 |
-32%
|
| Country Average | 1.7 | CA$0.63 |
+15%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
C
|
Canada House Cannabis Group Inc
CNSX:CHV
|
25.4m CAD | 1.5 | -28.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883B USD | 9.4 | 44.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.5B USD | 3.4 | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 2.9 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP | 3.7 | 27.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF | 2.9 | 20.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.2B USD | 2.6 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 56 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 2.7 | 12.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 1 | 19.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2 | 16.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1 |
| Median | 1.7 |
| 70th Percentile | 3.7 |
| Max | 95 179.6 |
Other Multiples
Canada House Cannabis Group Inc
Glance View
Canada House Wellness Group, Inc. is an integrated medical cannabis company. The company is headquartered in Pickering, Ontario. The company went IPO on 2000-06-27. The firm's operated subsidiaries are: Canada House Clinics, Knalysis Technologies Inc and Abba Medix Corp. Its Canada House Clinics is focused on treating complex health issues through assessments, ongoing support, and data-driven treatment plans that are monitored by cannabinoid therapy educators. Its Knalysis Technologies, is a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Its Abba Medix Corp is engaged in producing cannabis genetics and products in a fully integrated seed-to-sale vertical and links the growth operations, patient services, and offers artificial intelligence (AI) assisted data reporting solutions.
